WuXi Biologics WKN: A2QJCN ISIN: KYG970081173 Forum: Aktien User: Summer.76

WuXi Biologics: Geopolitical Risks Draw Investors' Attention https://seekingalpha.com/article/4545243-wuxi-biologics-geopolitical-risks-draw-investors-attention

U.S. adds China's YMTC and 30 other firms to 'unverified' trade list https://www.reuters.com/business/us-adds-dozens-chinese-firms-export-control-list-2022-10-07/ ... The United States removed a unit of Wuxi Biologics from the list on Friday, good news for the maker of ingredients for AstraZeneca's COVID-19 vaccine. Reuters reported last summer that U.S. officials had been able to conduct an inspection at the Wuxi city site, a stepping stone to removal from the list. A Wuxi Biologics spokeswoman said on Friday the company was pleased the Wuxi site was removed from the list, given the inspection in June. The company looks forward to scheduling an inspection of its Shanghai subsidiary, which also was placed on the unverified list in February, she added.

http://www.aastocks.com/tc/stocks/news/AAFN-news/NOW.1217190/1

https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/bullish-insiders-at-wuxi-biologics-cayman-inc-hkg2269-loaded

https://spectrumnews1.com/ma/worcester/news/2022/09/27/wuxi-holds-topping-off-ceremony-for-new-worcester-facility

https://hk.investing.com/news/stock-market-news/article-256701

Wuxi Biologics Shares Jump After Buyback Plans https://www.morningstar.com/news/dow-jones/202209251172/wuxi-biologics-shares-jump-after-buyback-plans

http://www.aastocks.com/tc/stocks/news/aafn-news/NOW.1215168/1

https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/with-46-ownership-wuxi-biologics-cayman-inc-hkg2269-boasts-o

https://www.prnewswire.com/news-releases/wuxi-biologics-drug-substance-and-drug-product-facilities-again-approved-by-us-fda-and-ema-301627740.html

https://www.scmp.com/business/companies/article/3192919/us-china-relations-bidens-biotech-plan-has-limited-near-term

Biotech May Be the Next U.S.-China Battleground Investors in Chinese biotech—and perhaps their U.S. clients too—should be prepared for a rough ride https://www.wsj.com/articles/biotech-may-be-the-next-u-s-china-battleground-11663231969

http://www.aastocks.com/tc/stocks/news/aafn-con/now.1213515/latest-news

WuXi Biologics (02269) rose more than 7%, led by CRO concept stocks, said the US biomanufacturing bill had limited short- and medium-term impact https://finance.sina.cn/hkstock/sckxjfx/2022-09-15/detail-imqmmtha7376234.d.html?from=wap

Chinese biomed firms take ill on Biden’s decoupling order Top Chinese biomed stocks fall as US looks to reduce its reliance on foreign labs in latest tech sector to face restrictions https://asiatimes.com/2022/09/chinese-biomed-firms-take-ill-on-bidens-decoupling-order/

Daiwa Cites WUXI BIO Confidence in Retaining US Clients; Potential Impact Unclear w/o Details http://www.aastocks.com/en/stocks/news/aafn-con/now.1213248/latest-news